Biomarkers of Cisplatin Resistance in Urothelial Bladder Cancer: HMGA2 and Survivin

被引：0
|
作者：
Reis, Henning [1 ]
Krafft, Ulrich [1 ]
Tschirdewahn, Stephan [1 ]
Hess, Jochen [1 ]
Harke, Nina [1 ]
Hadaschik, Boris [2 ]
Krege, Susanne [3 ]
Nyirady, Peter [4 ]
Szendroi, Attila [4 ]
Szucs, Miklos [4 ]
Modos, Orsolya [5 ]
Szekely, Eszter [6 ]
Szarvas, Tibor [1 ,4 ]
Szarvas, Tibor [1 ,4 ]
机构：
[1] Univ Duisburg Essen, West German Canc Ctr, Essen, Germany
[2] Univ Duisburg Essen, Univ Hosp Essen, Essen, Germany
[3] Kliniken Essen Mitte, Essen, Germany
[4] Semmelweis Univ, Budapest, Hungary
[5] Semmelweis Univ, Clin Urol, Budapest, BP, Hungary
[6] Semmelweis Univ, Univ Hosp Budapest, Budapest, Hungary
来源：
LABORATORY INVESTIGATION | 2019年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
938
引用
收藏
页数：1
相关论文
共 50 条
  • [41] HMGA2 gene is a promising target for ovarian cancer silencing therapy
    Malek, Anastasia
    Bakhidze, Elena
    Noske, Aurelia
    Sers, Christine
    Aigner, Achim
    Schaefer, Reinhold
    Tchernitsa, Oleg
    INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (02) : 348 - 356
  • [42] HMGA2 overexpression in non-small cell lung cancer
    Meyer, Britta
    Loeschke, Siegfried
    Schultze, Anke
    Weigel, Thomas
    Sandkamp, Martin
    Goldmann, Torsten
    Vollmer, Ekkehard
    Bullerdiek, Joern
    MOLECULAR CARCINOGENESIS, 2007, 46 (07) : 503 - 511
  • [43] Prognostic value of miR-26a and HMGA1 in urothelial bladder cancer
    Lin, Rongkai
    Shen, Wenhao
    Zhi, Yi
    Zhou, Zhansong
    BIOMEDICINE & PHARMACOTHERAPY, 2014, 68 (08) : 929 - 934
  • [44] RETRACTION: LncRNA ANRIL affects the sensitivity of ovarian cancer to cisplatin via regulation of let-7a/HMGA2 axis
    不详
    BIOSCIENCE REPORTS, 2024, 44 (07)
  • [45] Exploring Contribution of HMGA2 to the Aggressive Tumor Structure in Urothelial Carcinoma to Identify Prospective Clinical Applications
    Liu, Hui-Ying
    Luo, Hao-Lun
    PHYSIOLOGY, 2024, 39
  • [46] TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approach
    Cheraghi-shavi, Tayebeh
    Jalal, Razieh
    Minuchehr, Zarrin
    PLOS ONE, 2023, 18 (08):
  • [47] Molecular mechanisms of cisplatin resistance in bladder cancer
    Drayton, Ross M.
    Catto, James W. F.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (02) : 271 - 281
  • [48] Prioritizing potential circRNA biomarkers for bladder cancer and bladder urothelial cancer based on an ensemble model
    Su, Qiongli
    Tan, Qiuhong
    Liu, Xin
    Wu, Ling
    FRONTIERS IN GENETICS, 2022, 13
  • [49] Neoadjuvant gemcitabine and cisplatin chemotherapy for locally advanced urothelial cancer of the bladder
    Scosyrev, Emil
    Messing, Edward M.
    van Wijngaarden, Edwin
    Peterson, Derick R.
    Sahasrabudhe, Deepak
    Golijanin, Dragan
    Fisher, Susan G.
    CANCER, 2012, 118 (01) : 72 - 81
  • [50] Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway
    Zhao, Xiao-Peng
    Zhang, Hong
    Jiao, Jiu-Yang
    Tang, Dong-Xiao
    Wu, Yu-ling
    Pan, Chao-Bin
    JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
12345